MedPath

Visuospatial and Affective Abilities in Parkinson Disease

Not Applicable
Not yet recruiting
Conditions
Parkinson Disease
Visuospatial/Perceptual Abilities
Alexithymia
Interventions
Other: Prismatic adaptation
Registration Number
NCT06341829
Lead Sponsor
IRCCS Centro Neurolesi "Bonino-Pulejo"
Brief Summary

The aim of the study is to investigate whether prismatic adaptation (AP), a non-invasive neuromodulation technique, that involves the use of lenses that deviate the visual field, can modulate alexithyima and performance in visuospatial tasks in patients with Parkinson disease. Furthermore, brain activity during the prismatic adaptation and post-adaptation phases will be recorded using functional near-infrared spectroscopy (fNIRS) and high-density electroencephalography (HD-EEG).

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Over 18 years old;
  • Right-handed;
  • Diagnosis of idiopathic Parkinson's disease according to the UK Brain Bank criteria (Lyon and Pahwa, 2011);
  • Hoehn and Yahr Stadium (Hoehn and Yahr, 1996) <2,5;
  • Stable pharmacological treatment (dopaminergic therapy: dopamine agonists and Levo-dopa) in the last 6 weeks.
Exclusion Criteria
    • Sensory-motor deficits that can hinder neuropsychological assessment;
  • Visual system disorders (blindness, glaucoma);
  • Atypical parkinsonisms;
  • PD with dementia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (American Psychiatric Association).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Left prismatic adaptationPrismatic adaptationThis group will undergo left prismatic adaptation
Right prismatic adaptationPrismatic adaptationThis group will undergo right prismatic adaptation
Neutral prismatic adaptationPrismatic adaptationThis group will undergo neutral lenses
Primary Outcome Measures
NameTimeMethod
Improve visuospatial skills;2 years

Better performance in tests that evaluate visuospatial skills like line bisection test. The minimun value is 0 and the maximum is 3. Higher scores mean a worse outcome

Modulate alexithymia;2 years

improvement in tests evaluating alexithymia such as TAS-20. The TAS 20 has scores that have a minimum of 20 and a maximum of 100. Scores greater than or equal to 61indicate high levels of alexithymia

Investigation of brain activity;2 years

investigate the brain areas involved in the tasks with High Density Electroencephalography (EEG HD) and functional near infrared spectroscopy (fNIRS). The most active areas will be listed in a table

Secondary Outcome Measures
NameTimeMethod
Improve the quality of life with PDQ-39 questionnaire2 years

Promote rewarding experiences that improve self-esteem, the perceived sense of self-efficacy, the quality of life measured with the Parkinson's disease questionnaire (PDQ-39).The minimum score is 0 which indicates the best quality of life A maximum score is 100 which indicates the worst quality of life.

© Copyright 2025. All Rights Reserved by MedPath